June 2009

TWiV 35: Much achoo about nothing

In episode 35 of the podcast “This Week in Virology”, Vincent, Alan, Dick, and Richard Kessin talk about Lujo virus, a new arenavirus, influenza, WHO rewriting pandemic rules, adjuvants, and a brief history of microbiology. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV035.mp3″] Click the arrow above to play, or right-click to download TWiV #35 or subscribe in iTunes or by …

TWiV 35: Much achoo about nothing Read More »

Interferons and secondary pneumonia after influenza

Now that we have discussed influenza pathogenesis in humans and the innate immune defenses, we can tackle the conclusion that type I IFN mediates the development of secondary bacterial pneumonia in mice. Secondary bacterial pneumonia occurs after the patient has begun to recover from influenza infection, and often influenza virus can no longer be isolated. …

Interferons and secondary pneumonia after influenza Read More »

How influenza virus inhibits early antiviral responses

The fact that viruses routinely and frequently cause disease shows that our defense mechanisms are imperfect. This occurs in large part because nearly every viral genome encodes one or more countermeasures to modulate host defenses. Influenza virus is no exception. One of the viral proteins, called NS1, is particularly adept at impairing the synthesis of …

How influenza virus inhibits early antiviral responses Read More »

Pathogenesis of influenza in humans

When influenza virus is introduced into the respiratory tract, by aerosol or by contact with saliva or other respiratory secretions from an infected individual, it attaches to and replicates in epithelial cells. The virus replicates in cells of both the upper and lower respiratory tract. Viral replication combined with the immune response to infection (which …

Pathogenesis of influenza in humans Read More »

Scroll to Top